|
1.
|
Early Breast Cancer Trialists’
Collaborative Group (EBCTCG); Davies C, Godwin J, Gray R, et al:
Relevance of breast cancer hormone receptors and other factors to
the efficacy of adjuvant tamoxifen: patient-level meta-analysis of
randomised trials. Lancet. 378:771–784. 2011. View Article : Google Scholar
|
|
2.
|
Ford CH, Al-Bader M, Al-Ayadhi B and
Francis I: Reassessment of estrogen receptor expression in human
breast cancer cell lines. Anticancer Res. 31:521–527.
2011.PubMed/NCBI
|
|
3.
|
Wiechmann L, Sampson M, Stempel M, et al:
Presenting features of breast cancer differ by molecular subtype.
Ann Surg Oncol. 16:2705–2710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Yamashita H, Ando Y, Nishio M, et al:
Immunohistochemical evaluation of hormone receptor status for
predicting response to endocrine therapy in metastatic breast
cancer. Breast Cancer. 13:74–83. 2006. View Article : Google Scholar
|
|
5.
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
6.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
7.
|
Blenkiron C, Goldstein LD, Thorne NP, et
al: MicroRNA expression profiling of human breast cancer identifies
new markers of tumor subtype. Genome Biol. 8:R2142007. View Article : Google Scholar
|
|
8.
|
Lowery AJ, Miller N, Devaney A, et al:
MicroRNA signatures predict estrogen receptor, progesterone
receptor and HER2/neu receptor status in breast cancer. Breast
Cancer Res. 11:R272009. View
Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 Expression is down-regulated in estrogen
receptor alpha-positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Adams BD, Furneaux H and White BA: The
micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen
receptor-alpha (ERalpha) and represses ERalpha messenger RNA and
protein expression in breast cancer cell lines. Mol Endocrinol.
21:1132–1147. 2007. View Article : Google Scholar
|
|
11.
|
Leivonen SK, Mäkelä R, Ostling P, Kohonen
P, Haapa-Paananen S, et al: Protein lysate microarray analysis to
identify microRNAs regulating estrogen receptor signaling in breast
cancer cell lines. Oncogene. 28:3926–3936. 2009. View Article : Google Scholar
|
|
12.
|
Pandey DP and Picard D: miR-22 inhibits
estrogen signaling by directly targeting the estrogen receptor
alpha mRNA. Mol Cell Biol. 29:3783–3790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Xiong J, Yu D, Wei N, Fu H, Cai T, Huang
Y, et al: An estrogen receptor alpha suppressor, microRNA-22, is
downregulated in estrogen receptor alpha-positive human breast
cancer cell lines and clinical samples. FEBS J. 277:1684–1694.
2010. View Article : Google Scholar
|
|
14.
|
Zhao JJ, Lin J, Yang H, Kong W, He L, Ma
X, et al: MicroRNA-221/222 negatively regulates estrogen receptor
alpha and is associated with tamoxifen resistance in breast cancer.
J Biol Chem. 283:31079–31086. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Di Leva G, Gasparini P, Piovan C, Ngankeu
A, Garofalo M, Taccioli C, et al: MicroRNA cluster 221–222 and
estrogen receptor alpha interactions in breast cancer. J Natl
Cancer Inst. 102:706–721. 2010.
|
|
16.
|
Cittelly DM, Das PM, Spoelstra NS,
Edgerton SM, Richer JK, Thor AD and Jones FE: Downregulation of
miR-342 is associated with tamoxifen resistant breast tumors. Mol
Cancer. 9:3172010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bozzetti C, Nizzoli R, Guazzi A, Flora W,
Bassano C, et al: HER2/neu amplification detected by fluorescence
in situ hybridization in fine needle aspirates from primary breast
cancer. Ann Oncol. 13:1398–1403. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Obrero M, Yu DV and Shapiro DJ: Estrogen
receptor-dependent and estrogen receptor-independent pathways for
tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J
Biol Chem. 277:45695–45703. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar
|
|
20.
|
Wang H, Wu J, Meng X, et al: MicroRNA-342
inhibits colorectal cancer cell proliferation and invasion by
directly targeting DNA methyltransferase 1. Carcinogenesis.
32:1033–1042. 2011. View Article : Google Scholar : PubMed/NCBI
|
